These results from the docking simulation of the 5 targets (ESR1, ESR2, TP53, SRC, VDR) highly suggests a role for the targets in the mechanism of germacrone, curdione, and furanodiene in treating breast cancer. The gene discussed is ESR1; the disease is breast cancer.